Binding of the PD-1 protein, which is expressed mainly in T lymphocytes, to the PD-L1 molecule present on cancer cells, leads to the inhibition of the T cell-dependent immune response and is one of the important mechanisms of the tumour escaping the surveillance of the immune system. Here, PDCD1 is linked to neoplasm.